Literature DB >> 25673043

Formulation, Characterization, and Antitumor Properties of Trans- and Cis-Citral in the 4T1 Breast Cancer Xenograft Mouse Model.

San Zeng1, Arvinder Kapur, Manish S Patankar, May P Xiong.   

Abstract

PURPOSE: Citral is composed of a random mixture of two geometric stereoisomers geranial (trans-citral) and neral (cis-citral) yet few studies have directly compared their in vivo antitumor properties. A micelle formulation was therefore developed.
METHODS: Geranial and neral were synthesized. Commercially-purchased citral, geranial, and neral were formulated in PEG-b-PCL (block sizes of 5000:10,000, Mw/Mn 1.26) micelles. In vitro degradation, drug release, cytotoxicity, flow cytometry, and western blot studies were conducted. The antitumor properties of drug formulations (40 and 80 mg/kg based on MTD studies) were evaluated on the 4T1 xenograft mouse model and tumor tissues were analyzed by western blot.
RESULTS: Micelles encapsulated drugs with >50% LE at 5-40% drug to polymer (w/w), displayed sustained release (t1/2 of 8-9 h), and improved drug stability at pH 5.0. The IC50 of drug formulations against 4T1 cells ranged from 1.4 to 9.9 μM. Western blot revealed that autophagy was the main cause of cytotoxicity. Geranial at 80 mg/kg was most effective at inhibiting tumor growth.
CONCLUSIONS: Geranial is significantly more potent than neral and citral at 80 mg/kg (p < 0.001) and western blot of tumor tissues confirms that autophagy and not apoptosis is the major mechanism of tumor growth inhibition in p53-null 4T1 cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25673043      PMCID: PMC4490114          DOI: 10.1007/s11095-015-1643-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  24 in total

Review 1.  Deconvoluting the context-dependent role for autophagy in cancer.

Authors:  Eileen White
Journal:  Nat Rev Cancer       Date:  2012-04-26       Impact factor: 60.716

2.  In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration.

Authors:  Jubo Liu; Faquan Zeng; Christine Allen
Journal:  Eur J Pharm Biopharm       Date:  2006-11-23       Impact factor: 5.571

3.  The inhibition of growth or cell division in Escherichia coli by different ionic species of platinum(IV) complexes.

Authors:  B Rosenberg; L Van Camp; E B Grimley; A J Thomson
Journal:  J Biol Chem       Date:  1967-03-25       Impact factor: 5.157

Review 4.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

Authors:  H Maeda; J Wu; T Sawa; Y Matsumura; K Hori
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

5.  Antioxidant activity of plant extracts on the inhibition of citral off-odor formation.

Authors:  Chia-Pei Liang; Mingfu Wang; James E Simon; Chi-Tang Ho
Journal:  Mol Nutr Food Res       Date:  2004-09       Impact factor: 5.914

6.  Autophagy proteins LC3B, ATG5 and ATG12 participate in quality control after mitochondrial damage and influence lifespan.

Authors:  Sören Mai; Britta Muster; Jürgen Bereiter-Hahn; Marina Jendrach
Journal:  Autophagy       Date:  2012-01-01       Impact factor: 16.016

7.  Assessment of the integrity of poly(caprolactone)-b-poly(ethylene oxide) micelles under biological conditions: a fluorogenic-based approach.

Authors:  Radoslav Savić; Tony Azzam; Adi Eisenberg; Dusica Maysinger
Journal:  Langmuir       Date:  2006-04-11       Impact factor: 3.882

8.  Inhibition of citral degradation in an acidic aqueous environment by polyoxyethylene alkylether surfactants.

Authors:  Masrat Maswal; Aijaz Ahmad Dar
Journal:  Food Chem       Date:  2012-12-28       Impact factor: 7.514

9.  Poly(aspartate-g-PEI800), a polyethylenimine analogue of low toxicity and high transfection efficiency for gene delivery.

Authors:  May P Xiong; M Laird Forrest; Giangthy Ton; Anni Zhao; Neal M Davies; Glen S Kwon
Journal:  Biomaterials       Date:  2007-08-10       Impact factor: 12.479

10.  Chemical and physical stability of citral and limonene in sodium dodecyl sulfate-chitosan and gum arabic-stabilized oil-in-water emulsions.

Authors:  Darinka Djordjevic; Luisito Cercaci; Jean Alamed; D Julian McClements; Eric A Decker
Journal:  J Agric Food Chem       Date:  2007-04-10       Impact factor: 5.279

View more
  11 in total

1.  Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3.

Authors:  Margaret Lois Thomas; Roberto de Antueno; Krysta Mila Coyle; Mohammad Sultan; Brianne Marie Cruickshank; Michael Anthony Giacomantonio; Carman Anthony Giacomantonio; Roy Duncan; Paola Marcato
Journal:  Mol Oncol       Date:  2016-08-25       Impact factor: 6.603

2.  Modulation of oxidative stress and subsequent induction of apoptosis and endoplasmic reticulum stress allows citral to decrease cancer cell proliferation.

Authors:  Arvinder Kapur; Mildred Felder; Lucas Fass; Justanjot Kaur; Austin Czarnecki; Kavya Rathi; San Zeng; Kathryn Kalady Osowski; Colin Howell; May P Xiong; Rebecca J Whelan; Manish S Patankar
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

3.  Citral induced apoptosis in MDA-MB-231 spheroid cells.

Authors:  Siyamak Ebrahimi Nigjeh; Swee Keong Yeap; Norshariza Nordin; Behnam Kamalideghan; Huynh Ky; Rozita Rosli
Journal:  BMC Complement Altern Med       Date:  2018-02-13       Impact factor: 3.659

4.  Cytotoxic and Antimicrobial Constituents from the Essential Oil of Lippia alba (Verbenaceae).

Authors:  Nara O Dos Santos; Renata C Pascon; Marcelo A Vallim; Carlos R Figueiredo; Marisi G Soares; João Henrique G Lago; Patricia Sartorelli
Journal:  Medicines (Basel)       Date:  2016-08-12

5.  Diastereoselective synthesis of chiral 1,3-cyclohexadienals.

Authors:  Aitor Urosa; Ignacio E Tobal; Ángela P de la Granja; M Carmen Capitán; R F Moro; Isidro S Marcos; Narciso M Garrido; Francisca Sanz; Emilio Calle; David Díez
Journal:  PLoS One       Date:  2018-02-13       Impact factor: 3.240

6.  Induction of programmed cell death in Trypanosoma cruzi by Lippia alba essential oils and their major and synergistic terpenes (citral, limonene and caryophyllene oxide).

Authors:  Érika Marcela Moreno; Sandra Milena Leal; Elena E Stashenko; Liliana Torcoroma García
Journal:  BMC Complement Altern Med       Date:  2018-07-27       Impact factor: 3.659

7.  In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells.

Authors:  Noraini Nordin; Swee Keong Yeap; Heshu Sulaiman Rahman; Nur Rizi Zamberi; Nadiah Abu; Nurul Elyani Mohamad; Chee Wun How; Mas Jaffri Masarudin; Rasedee Abdullah; Noorjahan Banu Alitheen
Journal:  Sci Rep       Date:  2019-02-07       Impact factor: 4.379

8.  Tunable Production of (R)- or (S)-Citronellal from Geraniol via a Bienzymatic Cascade Using a Copper Radical Alcohol Oxidase and Old Yellow Enzyme.

Authors:  David Ribeaucourt; Georg T Höfler; Mehdi Yemloul; Bastien Bissaro; Fanny Lambert; Jean-Guy Berrin; Mickael Lafond; Caroline E Paul
Journal:  ACS Catal       Date:  2022-01-04       Impact factor: 13.084

9.  Essential oil from Cymbopogon citratus exhibits "anti-aspergillosis" potential: in-silico molecular docking and in vitro studies.

Authors:  Arun Dev Sharma; Inderjeet Kaur
Journal:  Bull Natl Res Cent       Date:  2022-01-29

10.  In Vivo Anti-Tumor Effects of Citral on 4T1 Breast Cancer Cells via Induction of Apoptosis and Downregulation of Aldehyde Dehydrogenase Activity.

Authors:  Siyamak Ebrahimi Nigjeh; Swee Keong Yeap; Norshariza Nordin; Heshu Rahman; Rozita Rosli
Journal:  Molecules       Date:  2019-09-05       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.